Patient education would aid compliance

Article

To help improve compliance, patients should be made aware of what a normal intraocular pressure (IOP) is and be informed of their own at each visit to their ophthalmologist, according to Rohit Arora and colleagues from the North Middlesex Hospital, UK.

To help improve compliance, patients should be made aware of what a normal intraocular pressure (IOP) is and be informed of their own at each visit to their ophthalmologist, according to Rohit Arora and colleagues from the North Middlesex Hospital, UK.

In their study, a structured questionnaire was completed by 100 patients attending a glaucoma clinic with chronic open angle glaucoma and ocular hypertension. Questions related to field defects, IOP, treatment and compliance. Their aim was to test patients' knowledge of the condition and therapy and to relate this to treatment compliance.

The investigators found that 13% of patients were unaware that they had glaucoma, however, 87% were aware that the disease has a very serious effect on vision. Forty-seven percent were able to accurately remember the name of their drops, 30% had an appropriate idea but 23% had no idea.

In terms of compliance, 18% depended on family members for the drops, 53% claimed full compliance, 14% admitted to forgetting their drops once in every 15 days, 14% would forget once a month and 20% would forget once in every six months. The main causes of non-compliance were holidays and general forgetfulness.

A significant number, 87%, had no idea about their own IOP and about the pressure range of a normal eye, whilst 80% did not understand the technique or relevance of the field tests. Sixty-four percent were unaware of alternative treatment options and 73% did not know of the existence of helplines and societies.

The team concluded from the study that patients needed to be further educated about the nature of their disease as this would serve to enhance compliance.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.